Tab Application Banner
  • Users Online: 335
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

LETTER TO THE EDITOR

Rituximab in biologically naïve rheumatoid arthritis patients and methotrexate non-responders - An Indian experience

Santhanam Sham, Sankaralingam Rajeswari, Natesan Tamilselvam Tirunchengodu, Mani Madeshwaran

Year : 2015| Volume: 10| Issue : 3 | Page no: 177-178

   This article has been cited by
 
1 Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India
Keerthi Talari,Vinod Ravindran,Pradip Kumar,Pravin Patil,SarathChandra Mouli,Syamasis Bandyopadhyay,BalebailG Dharmanand,Abhrajit Ray,Shankaralingam Rajeshwari,SanjivN Amin,Jyotsna Oak,Ved Chaturvedi,AnandN Malaviya,Sukumar Mukherjee
Indian Journal of Rheumatology. 2021; 0(0): 0
[Pubmed]  [Google Scholar] [DOI]
2 Safety and efficacy of an Anti-CD20 Monoclonal antibody (RedituxTM) In Indian patients with seropositive rheumatoid arthritis
Arun Hegde,Vivek Vasdev,Krishnan Shanmuganandan,Kavita Singh,Sivasami Kartik,Abhishek Kumar
Indian Journal of Rheumatology. 2018; 13(1): 20
[Pubmed]  [Google Scholar] [DOI]

 

Read this article